女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识

2020-09-30 中国肿瘤科相关专家小组(统称) 实用妇产科杂志.2020.36(9):667-670.-

在全球范围内,恶性肿瘤的发病率呈现逐年上升及年轻化的趋势。近年来,得益于肿瘤普查及诊疗方法的改进,肿瘤患者的生存率显著提升。化疗是恶性肿瘤普遍且有效的治疗方法,使许多肿瘤患者预后有了明显改善,但是化疗

中文标题:

女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识

发布日期:

2020-09-30

简要介绍:

在全球范围内,恶性肿瘤的发病率呈现逐年上升及年轻化的趋势。近年来,得益于肿瘤普查及诊疗方法的改进,肿瘤患者的生存率显著提升。化疗是恶性肿瘤普遍且有效的治疗方法,使许多肿瘤患者预后有了明显改善,但是化疗药物在杀伤肿瘤细胞的同时,也不可避免地引起卵巢功能损伤,具体表现为发育迟滞、生育力下降甚至丧失、激素分泌减少或早绝经等问题。卵巢功能下降严重影响患者的生存质量和生命尊严,并且显著增加心血管疾病、骨质疏松及代谢紊乱等相关疾病的风险。近年来,女性恶性肿瘤患者化疗时卵巢功能保护的意识日益受到重视,并有诸多措施应用于临床实践。根据国内外的研究结果和指南,结合临床实践经验,通过充分讨论后制定了《女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识》,本共识旨在梳理相关理念,对化疗相关卵巢损伤的防治策略进行系统总结,为肿瘤患者卵巢功能的防护提供规范的临床诊疗流程,在确保抗肿瘤治疗疗效的前提下提升患者的生存质量。

相关资料下载:
[AttachmentFileName(sort=1, fileName=女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识_王世宣.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a0c251c001995574, title=女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识, enTitle=, guiderFrom=实用妇产科杂志.2020.36(9):667-670.-, authorId=0, author=, summary=在全球范围内,恶性肿瘤的发病率呈现逐年上升及年轻化的趋势。近年来,得益于肿瘤普查及诊疗方法的改进,肿瘤患者的生存率显著提升。化疗是恶性肿瘤普遍且有效的治疗方法,使许多肿瘤患者预后有了明显改善,但是化疗, cover=https://img.medsci.cn/20201023/1603467895082_2020535.jpg, journalId=0, articlesId=null, associationId=747, associationName=中国肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Sep 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>在全球范围内,恶性肿瘤的发病率呈现逐年上升及年轻化的趋势。近年来,得益于肿瘤普查及诊疗方法的改进,肿瘤患者的生存率显著提升。化疗是恶性肿瘤普遍且有效的治疗方法,使许多肿瘤患者预后有了明显改善,但是化疗药物在杀伤肿瘤细胞的同时,也不可避免地引起卵巢功能损伤,具体表现为发育迟滞、生育力下降甚至丧失、激素分泌减少或早绝经等问题。卵巢功能下降严重影响患者的生存质量和生命尊严,并且显著增加心血管疾病、骨质疏松及代谢紊乱等相关疾病的风险。近年来,女性恶性肿瘤患者化疗时卵巢功能保护的意识日益受到重视,并有诸多措施应用于临床实践。根据国内外的研究结果和指南,结合临床实践经验,通过充分讨论后制定了《女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识》,本共识旨在梳理相关理念,对化疗相关卵巢损伤的防治策略进行系统总结,为肿瘤患者卵巢功能的防护提供规范的临床诊疗流程,在确保抗肿瘤治疗疗效的前提下提升患者的生存质量。</p> </div> </div> </div>, tagList=[TagDto(tagId=3840, tagName=恶性肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3840, guiderKeyword=恶性肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3048, appHits=148, showAppHits=0, pcHits=466, showPcHits=2900, likes=2, shares=11, comments=5, approvalStatus=1, publishedTime=Sat Oct 24 00:09:27 CST 2020, publishedTimeString=2020-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Oct 23 23:45:00 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 05:32:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识_王世宣.pdf)])
女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识_王世宣.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=949719, encodeId=7221949e1916, content=学习了,很好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b65471363, createdName=ms4000002118425758, createdTime=Sat Mar 20 15:23:43 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904492, encodeId=61a9904492db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:35:42 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904491, encodeId=7c06904491b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:35:34 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2021-03-20 ms4000002118425758

    学习了,很好!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=949719, encodeId=7221949e1916, content=学习了,很好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b65471363, createdName=ms4000002118425758, createdTime=Sat Mar 20 15:23:43 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904492, encodeId=61a9904492db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:35:42 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904491, encodeId=7c06904491b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:35:34 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2020-12-03 12544b9em05暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=949719, encodeId=7221949e1916, content=学习了,很好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24b65471363, createdName=ms4000002118425758, createdTime=Sat Mar 20 15:23:43 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904492, encodeId=61a9904492db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:35:42 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904491, encodeId=7c06904491b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:35:34 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2020-12-03 12544b9em05暂无昵称

    学习了

    0

拓展阅读

中国多发性骨髓瘤诊治指南(2015年修订)

中国医师协会血液科医师分会 · 2015-12-01

2015 ASGE指南:内镜在胃癌前病变和恶性肿瘤管理中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-04-29

2017 SGO建议:妇科恶性肿瘤复发治疗后监测和诊断

美国妇科肿瘤学会(SGO,Society of Gynecologic Oncology) · 2017-03-31

恶性肿瘤患者康复期营养管理专家共识

中国营养学会(CNS,Chinese Nutrition Society) · 2017-10-12